Article

Rasal1 impairment unleashes anticancer immunity - a focus on T cells

2026-01-20

Abstract excerpt

<h4>ABSTRACT</h4> Immune checkpoint blockade (ICB) has demonstrated clinical efficacy in several cancers, including melanoma, lung, colorectal, and liver malignancies. However, a substantial proportion of patients fail to respond, underscoring the need for alternative immunotherapeutic strategies capable of overcoming resistance to conventional checkpoint inhibition. One such strategy involves targeting intracell...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b0004036-5f06-5c49-be59-76035ede313f
DOI: 10.64898/2026.01.19.700452

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Rasal1 impairment unleashes anticancer immunity - a focus on T cellsDOI 10.64898/2026.01.19.700452Read

The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?Semantic proximity Read

T cell-specific loss of IRF1 results in defective CD8 T cell activation and antitumor immunitySemantic proximity Read

RAS signaling and immune cells: a sinister crosstalk in the tumor microenvironmentSemantic proximity Read

Genetic Dysregulation of Immunologic and Oncogenic Signaling Pathways Associated with Tumor-intrinsic Immune Resistance: A Molecular Basis for Combination Targeted Therapy-Immunotherapy for CancerSemantic proximity Read

<i>Setdb1</i> -loss induces type-I interferons and immune clearance of melanomaSemantic proximity Read

Immune responses in genomically simple SWI/SNF-deficient cancers.Semantic proximity Read

In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras -Mutant Lung AdenocarcinomaSemantic proximity Read

Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 ImmunotherapySemantic proximity Read

Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editingSemantic proximity Read

RASAL3 regulates RAC/CDC42 GTPases, SAPK/JNK signaling, IL-2 gene activity, and directed motility in human T cellsSemantic proximity Read

Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade.Semantic proximity Read

Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape.Semantic proximity Read